NewMarketFRA:UG9 +1.50%79 EBITDA Margin % is 28.68% as of Mar. 2026, which is 43% above its 10-year median of 20.12. GuruFocus rates FRA:UG9 with a GF Score™ of 79/100 and a GF Value™ of €483.64 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,584 Chemicals companies, NewMarket ranks better than 91.86% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. NewMarket's EBITDA for the
three
months ended in Mar. 2026 was €166 Mil. NewMarket's Revenue for the
three
months ended in Mar. 2026 was €579 Mil. Therefore, NewMarket's EBITDA margin for the quarter that ended in Mar. 2026 was 28.68%.
NewMarket (FRA:UG9) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
NewMarket EBITDA Margin % Related Terms
NewMarket EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for NewMarket's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:UG9 vs AXTA, EMN, PRM: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, NewMarket's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NewMarket EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, NewMarket's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where NewMarket's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NewMarket (FRA:UG9) has a EBITDA Margin % of 28.68% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NewMarket and its competitors. This is 43% above median its historical median of 20.12. Over the past decade, NewMarket's EBITDA Margin % has ranged from 15.54 to 27.22. According to the industry distribution chart, NewMarket ranks #129 out of 1584 companies in the Chemicals industry, placing it in the top 8.1%.
Is NewMarket's EBITDA Margin % too high?
NewMarket's current EBITDA Margin % of 28.68% is 43% above median its 10-year median of 20.12. Over the past 10 years, this metric has ranged from a low of 15.54 to a high of 27.22. The Chemicals industry median EBITDA Margin % is 9.64. NewMarket's value of 28.68% is 197.7% above this industry median. Based on the distribution chart, NewMarket ranks #129 out of 1584 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, NewMarket has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NewMarket's EBITDA Margin % compare to AXTA and EMN?
According to the Chemicals industry distribution chart, NewMarket ranks #129 out of 1584 companies for EBITDA Margin %. This places NewMarket in the top 8% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.64. NewMarket's value of 28.68% is 197.7% above this benchmark. Historically, NewMarket's own EBITDA Margin % has ranged from 15.54 to 27.22 over the past decade. While the company's 10-year median is 20.12 vs. the industry median of 9.64, NewMarket has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NewMarket's current EBITDA Margin % of 28.68% is 197.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NewMarket and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NewMarket's current EBITDA Margin % is 28.68%, which is 43% above median its own 10-year median of 20.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewMarket stock overvalued right now?
Based on GuruFocus' analysis, NewMarket (FRA:UG9) is currently considered Significantly Overvalued. The stock's GF Value™ is €483.64, compared to a current price of €675.00 — trading 39.6% above its estimated fair value. The current EBITDA Margin % is 28.68%, which is 43% above median its 10-year median of 20.12 and 197.7% above the Chemicals industry median of 9.64. NewMarket's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For NewMarket (FRA:UG9), the current EBITDA Margin % is 28.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NewMarket (FRA:UG9) Overvalued in 2026?
Based on GuruFocus' analysis, NewMarket stock appears to be overvalued.
The current stock price of €675.00 is trading 39.6% above its estimated GF Value™ of €483.64.
GuruFocus considers NewMarket to be Significantly Overvalued.
Key valuation signals for FRA:UG9:
EBITDA Margin %: 28.68% (43% above median its 10-year median of 20.12)
GF Value™: €483.64 vs. price of €675.00 (39.6% above fair value)
Industry Position: 197.7% above the Chemicals median (#129 of 1584)
No single metric tells the full story. See the FRA:UG9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives used in lubricating oils and fuels to enhance performance. The company operates through two segments: petroleum additives, mainly represented by Afton, where lubricant additives improve the efficiency and durability of base fluids and fuel additives help meet fuel specifications and improve fuel performance, and specialty materials, represented by AMPAC and Calca, including the antiknock compounds business of Ethyl, where primary raw materials include electricity, sodium chlorate, ammonia, chlorine, caustic, and hydrochloric acid, with graphite used in electrolytic cells. The company has operations in North America, Latin America, Asia Pacific, and EMEAI regions.
79GF Score
Get the complete analysis for FRA:UG9
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:UG9 has been successfully added to your 
